Pharmacokinetics in Early Drug Research: The Report and Recommendations of ECVAM Workshop 22

Alternatives to Laboratory Animals

Volumn 25, Issue 1, 1997, Pages 17-31

  Leahy, David E ^a   Duncan, Ruth ^b   Ahr, Hans J ^c   Bayliss, Martin K ^d   De Boer, A G ^e   Darvas, Ferenc ^f   Fentem, Julia H ^g   Fry, Jeffrey R ^h   Hopkins, Robert ⁱ   Houston, J Brian ^j   Karlsson, Johan ^k   Kedderis, Gregory L ^l   Pratten, Margaret K ^h   Prieto, Pilar ^g   Smith, Dennis A ^m   Straughan, Donald W ⁿ  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c BAYER AG   (Germany)

^d GLAXOSMITHKLINE   (United Kingdom)

^e LEIDEN UNIVERSITY   (Netherlands)

^f ComGenex Ltd ^*  (Hungary)

^g JOINT RESEARCH CENTRE   (Italy)

^h UNIVERSITY OF NOTTINGHAM   (United Kingdom)

ⁱ Corning Hazleton ^*  (United Kingdom)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

^k ELAN PHARMACEUTICALS   (United States)

^l CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^m PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

ⁿ RUSSELL AND BURCH HOUSE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2542644085     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119299702500105     Document Type: Article

References (57)

1. Anon (1994) ECVAM News & Views. ATLA 22, 7-11.
2. Gobas, F.A.PC, Lahittete, J M, Gorofalo, G., Shiu, W Y & MacKay, D. (1988) A novel method for measuring membrane-water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol-water paititioning, Journal of Pharmaceutical Science 77, 265-272
3. Watari, N., Sugiyama, Y , Kaneniwa, N & Hiura, M (1988) Prediction of hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit based on quantitative structure-pharmacokinetic relationships. Journal of Pharmacokinetics and Biopharmaceutics 16, 279-301
4. Blaauboer, B J , Boobis, A R , Castell, J.V , Coecke, S , Groothuis, G.M.M., Guillouzo, A., Hall, T.J., Hawkswrorth, G.M., Lorenzon, G., Miltenburger, H.G., Rogiers V., Skett, P., Villa, P. & Wiebel, F.J. (1994) The practical applicability of hepatocyte cultures in routine testing. The report and recommendations of ECVAM workshop 1. ATLA 22, 231-241.
5. Blaauboer, B.J., Bayliss, M.K., Castell, J.V., Evelo, C.T.A., Frazier, J.M., Groen, K., Gülden, M., Guillouzo, A., Hissink, A.M., Houston, J.B., Johanson, G., de Jongh, J., Kedderis, G.L., Reinhardt, C.A.., van de Sandt, J.J.M. & Semino, G. (1996), The use of biokinetics and in vitro methods in texicological risk evaluation. The report and recommendations of ECVAM workshop 15, ATLA 24, 473-497.
6. Iwatsube, T., Hirota, N., Ooie, T., Suzuki, H. & Sugiyama, Y. (1996). Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics. Biopharmaceutics and Drug Disposition 17, 273-319.
7. Charnick, S.B., Kawai, R., Nedelman, J.R., Lemaire, M., Niederberger, W. & Sato, H. (1995). Physiologically-based pharmacokinetic modelling as a tool for drug development. Journal of Pharmacokinetics and Biopkarmaceutics 23, 217-235.
8. Barratt, M.D., Castell, J.V., Combes, R.D., Dearden, J.C., Fentem, J.H., Gerner, I., Giuliani, A., Gray, T.J.B., Livingstone, D.J., Provan, W.M., Rutten, A.A.J.J.L., Verhaar, H.J.M. & Zbinden, P. (1995). The integrated use of alternative approaches for predicting toxic hazard. The report and recommendations of ECVAM workshop 8 ATLA 23, 410-429.
9. Sanderson, D.M & Earnshaw, G.G. (1991). Computer prediction of possible toxic action from chemical structure, the DEREK system. Human and Experimental Toxicology 106, 267-279.
10. bm3) Xenobiotica 25, 333-366.
11. Mancy, A., Broto, P., Dijols, S., Dansette, P.M. & Mansuy, D. (1995). The substrate binding site of human liver cytochrome P450 2C9: an approach using designed tienilic acid derivatives and molecular modelling. Biochemistry 34, 10365-10375.
12. Rietjens, I.M.C.M , Soffers, E.M.F., Veeger, C. & Vervoort. J (1993). Regioselectivity of cytochrome P450 catalysed hydroxylations of fluorobenzenes predicted by calculated frontier orbital substrate characteristics. Biochemistry 32, 4801-4812.
13. Lewis, D.F V. (1995). COMPACT and the importance of frontier orbitals in toxicity mediated by the cytochrom P450 mono-oxygenase system. Toxicology Modelling 1, 85-97
14. Dearden, J C., Barratt, M.D., Benigni, R , Bristol, D W, Combes, R.D , Cronin, M.T.D., Judson, P.N., Payne, M.P., Richard, A M., Tichy, M. & Yourick, J.J. The development and validation of expert systems for predicting toxicity. The report and recommendations of an ECVAM'ECB workshop. ATLA 25, in press
15. Houston, J.B. (1994). Utility of in vitro drug metabolic clearance data in predicting in vivo metabolic clearance. Biochemical Pharmacology 47, 1469-1479.
16. Bayliss, M.K., Bell, J.A., Jenner, W.N. & Wilson, K. (1990). The prediction of intrinsic clearance of loxtidine from kinetic studies in rat, dog and human hepatocytes. Biochemical Society Transactions 18, 1198-1199.
17. Frazier, J.M. (1995). Biokinetic modelling and in vitro assays. Application of in vitro systems to the prediction of in vivo biokinetics. Toxicology in Vitro 9, 527-536.
18. Artursson, P. (1990). Epithelial transport of drugs in cell culture. A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. Journal of Pharmaceutical Science 79, 476-482.
19. Hidalgo, I.J., Raub, T.J. & Borchardt, R.T. (1989). Characterisation of the human carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96, 736-749.
20. Dehouck, M.P., Jolliet-Riant, P., Bree, F., Fruchart, J.C., Cecchelli, R. & Tillement, J.P. (1992). Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models. Journal of Neurochemistry 58, 1790-1797.
21. Audus, K.L. & Borchardt, R.T. (1986). Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharmaceutical Research 3, 81-87.
22. Dehouck, M.P., Mresse, S., Delorme, P., Fruchart, J.C. & Cecchelli, R. (1990) An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. Journal of Neurochemistry 54, 1798-1801.
23. Rubin, L.L., Hall, D.E., Parter, S., Barbu, K., Cannon, C., Horner, H.C., Janatpour, M., Liaw, C.W., Manning, K., Morales, J., Tanner, L.I., Tomaselli K.J. & Bard, F. (1991). A cell culture model of the blood-brain barrier. Journal of Cell Biology 115, 1725-1735.
24. Artursson, P. & Karlsson, J. (1991). Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications 175, 880-885.
25. Atterwill, C K., Brainink, A., Drejer, J., Duarte, E., McFarlane Abdulla, E., Meredith, C., Nicotera, P., Regan, C , Rodríguez-Farré, E., Simpson, M.G., Smith, R., Veronesi, B., Vijverberg, H., Walum, E & Williams, D.C. (1994). In vitro neurotoxicity testing. The report and recommendations of ECVAM workshop 3. ATLA 22, 350-362.
26. Hawksworth, G.M., Bach, P.H., Nagelkerke, J.F., Dekant, W., Diezi, J.E., Harpur, E., Lock, E.A., MacDonald, C., Morin, J-P., Pfaller, W., Rutten, A.A.J.J.L., Ryan, M P., Toutain, H.J. & Trevisan, A. (1995). Nephrotoxicity testing in vitro. The report and recommendations of ECVAM workshop 10. ATLA 23, 713-727.
27. Seibert, H , Balls, M., Fentem, J.H., Bianchi, V., Clothier, R H., Dierickx, P J., Ekwall, B., Garle, M.J., Gómez-Lechón, M J., Gribaldo, L., Gülden, M., Liebsch, M., Rasmussen, E . Roguet, R., Shrivastava, R & Walum, E. (1996) Acute toxicity testing in vitro and the classification and labelling of chemicals. The report and recommendations of ECVAM workshop 16. ATLA 24, 499-510.
28. Garle, M.J. & Fry, J R. (1989). Detection of reactive metabolites in vitro. Toxicology 54, 101-110
29. 35S]-cysteine as trapping agents, to detect reactive intermediates of xenobiotics Toxicology in Vitro 2, 225-230.
30. Knobeloch, L M., Blondin, G.A., Lyford, S.B. & Harkin, J.M (1990) A rapid bioassay for chemicals that induce pro-oxidant states. Journal of Applied Toxicology 10, 1-5.
31. Gonzalez, F.J. & Korezekwa, K.R. (1995). Cytochrome P450 expression systems. Annual Reviews of Pharmacology and Toxicology 35, 369-390.
32. Duncan, R. (1992). Drug-polymer conjugates: potential for improved chemotherapy. Anti-Cancer Drugs 3, 175-210.
33. Duncan, R. & Spreafico, F. (1994). Polymer conjugates: pharmacokinetic considerations for design and development. Clinical Pharmacokinetics 27, 290-306.
34. Vasey, P.A., Duncan, R., Kaye, S.B. & Cassidy, J. (1995). Clinical Phase I trial (HPMA copolymer doxorubicin). European Journal of Cancer 31A, S193.
35. Artursson, P. (1991). Cell cultures as models for drug absorption across the intestinal mucosa. Critical Reviews of Therapeutic Drug Carrier Systems 8, 305-330.
36. Hillgren, K.M., Kato, A. & Borchardt, R.T. (1995). In vitro systems for studying intestinal drug absorption. Medical Research Reviews 15, 83-109.
37. Cogburn, J.N., Donovan, M G & Schasten, C.S. (1991). A model of human small intestinal absorptive cells. I. Transport barrier. Pharmaceutical Research 8, 210-216.
38. Rubas, W., Jezyk, N. & Grass, G.M. (1993). Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharmaceutical Research 10, 113-118.
39. Wils, A., Warney, A., Phung-Ba, V. & Scherman, D. (1994). Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs. Cell Biology and Toxicology 10, 393-397.
40. Rubas, W., Villagran, J., Cromwell, M., McLeod, A., Wassenberg, J. & Mesny. R. (1995). Correlation of solute flux across Caco-2 monolayers and colonic tissue in vitro. S.T.P. Pharmaceutical Sciences 1, 93-97.
41. Stewart, B H , Chan, H , Lu, R.H , Reyner, E.L., Schmid, H.L , Hamilton, H.W., Steinerg, B.A & Taylor, M.D. (1995). Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharmaceutical Research 12, 693-699.
42. Lennernas, H , Palm, K., Fagerholm. V. & Artursson, P. (1996). Correlation between paracellular and transcellular drug permeability in the human jejunum and Caco-2 monolayers. International Journal of Pharmaceutics 127, 103-107
43. Artursson, P . Ungell, A.L. & Lofroth, J.E. (1993). Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharmaceutical Research 10, 1123-1129.
44. Artursson, P., Karlsson, J., Ocklind, G & Schipper, N. (1996). Studying transport processes in absorptive epithelia. In Cell Culture Models of Epithelial Tissues - A Practical Approach (ed A. Shaw), pp. 111-133. New York: Oxford University Press.
45. Walter, E & Kissel, T (1994). Heterogeneity in the human intestinal cell iine Caco-2 leads to differences in transepithelial transport. European Journal of Pharmaceutical Science 3, 656-671.
46. Martin, Y.C. (1981). A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry. Journal of Medicinal Chemistry 24, 229-237.
47. 2 receptor histamine antagonists. Journal of Medicinal Chemistry 31, 656-671.
48. Wright, L.L. & Painter, G.R. (1992). Role of desolvation energy in the non-facilitated membrane permeability of dideoxyribose analogs of thymidine. Molecular Pharmacology 41, 957-962.
49. Palm, K., Luthman, K., Ungell, A.L., Strandlund, G. & Artursson, P. (1996). Correlation of drug absorption with molecular surface properties. Journal of Pharmaceutical Science 85, 32-39.
50. Stevenson, C.L., Augustijns, P.P. & Hendren, R.W. (1995). Permeability screen for synthetic peptide combinatorial libraries using Caco-2 cell monolayers and LC/MS/MS. Pharmaceutical Research 12, S94.
51. van Bree, J.B.M.M., de Boer, A.G., Danhof, M., Ginsel, L.A. & Breimer, D.D. (1988). Characterization of in vitro blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. Journal of Pharmacology and Experimental Therapeutics 247, 1233-1239.
52. van Bree, J.B M M., de Boer, A.G., Danhof, M. & Breimer, D.D. (1992) Drug transport across the blood-brain, barrier II. Experimental techniques to study drug transport. Pharmaceutica Weekblad (Sci) 14, 338-348.
53. Joo, F. (1993). The blood-brain barrier in vitro: the second decade. Neurochemistry International 23, 499-521.
54. Meyer, J., Rauh, J & Galla, H-J. (1991). The susceptibility of cerebral endothelial cells to astroglial induction of blood-brain barrier enzymes depends on their proliferative state. Journal of Neurochemistry 57, 1971-1977.
55. Mresse, S., Dehouck, M-P., Delorme, P., Bensad, M , Tauber, J P , Delbart, D., Fruchart, J-C. & Cecchelli, R. (1989) Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture Journal of Neurochemistry 53, 1363-1371
56. de Vries, H.E , Blom-Roosemalen. M.C.M , de Boer, A.G., van Berkel, T.J.C., Breimer, D.D. & Kuiper, J. (1996). Effect of endotoxin on the permeability of bovine cerebral endothelial cell layers in vitro. Journal of Pharmacology and Experimental Therapeutics 277, 1418-1423.
57. de Vries, H.E., Blom-Roosemalen, M.C.M., de Boer, A.G , van Berkel, T.J C., Breimer, D.D. & Kuiper. J (1996) The influence of cytokines on the integrity of the blood-brain barrier in vitro. Journal of Neuroimmunology 64, 37-43.